BE553401A - - Google Patents

Info

Publication number
BE553401A
BE553401A BE553401DA BE553401A BE 553401 A BE553401 A BE 553401A BE 553401D A BE553401D A BE 553401DA BE 553401 A BE553401 A BE 553401A
Authority
BE
Belgium
Prior art keywords
phenyl
piperidine
ethyl
added
propionoxy
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE553401A publication Critical patent/BE553401A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BE553401D BE553401A (de)

Publications (1)

Publication Number Publication Date
BE553401A true BE553401A (de)

Family

ID=178230

Family Applications (1)

Application Number Title Priority Date Filing Date
BE553401D BE553401A (de)

Country Status (1)

Country Link
BE (1) BE553401A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317548A (en) * 1964-10-30 1967-05-02 Rexall Drug Chemical 1-allyl-3-(substituted benzoyl)-4-(substituted phenyl)-4-hydroxypiperidines
DE1294381B (de) * 1961-03-06 1969-05-08 Boehringer Sohn Ingelheim 1-Cinnamyl-4-(3'-hydroxyphenyl)-4-propionylpiperidin, dessen Saeureadditionssalze sowie Verfahren zu deren Herstellung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1294381B (de) * 1961-03-06 1969-05-08 Boehringer Sohn Ingelheim 1-Cinnamyl-4-(3'-hydroxyphenyl)-4-propionylpiperidin, dessen Saeureadditionssalze sowie Verfahren zu deren Herstellung
US3317548A (en) * 1964-10-30 1967-05-02 Rexall Drug Chemical 1-allyl-3-(substituted benzoyl)-4-(substituted phenyl)-4-hydroxypiperidines

Similar Documents

Publication Publication Date Title
EP1708994B1 (de) Derivate vom aryloxyalkylcarbamat-typ, verfahren zu deren herstellung und deren verwendung in therapeutika
CA1280115C (fr) Derives de benzo¬b| thiophene et benzo¬b| furannecarboxamides, leurs procedes de preparation et les medicaments les contenant
WO2005090322A1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en tant qu’inhibiteurs de l’enzyme faah
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
WO2005090347A1 (fr) Derives d’aryl- et d’heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
EP0101381B1 (de) Trifluoromethylphenyltetrahydropyridine mit appetithemmender Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2493315A1 (fr) Derive de piperazine, procede pour sa preparation et composition analgesique en contenant
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
EP0069664A1 (de) Aminobenzamide, ihre Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
CH649994A5 (fr) Derives du 4h-1,2,4-triazole, procedes de preparation et compositions les renfermant.
FR2477150A1 (fr) Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
CH630606A5 (en) Phenylamidine derivatives useful especially in therapeutics
WO1999062900A1 (fr) Derives d'oxindole utile comme antagonistes des recepteurs de neurokinines
BE553401A (de)
EP0101379B1 (de) Benzamide, ihre Salze, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
EP0176444B1 (de) Verfahren zur Herstellung von 4H-1,2,4-Triazol-Derivaten, so erhaltene neue Triazole, ihre Verwendung als Arzneimittel und sie enthaltende pharmazeutische Zusammensetzungen
CA1100968A (fr) Procedes de preparation de nouvelles piperazines disubstituees
EP0275762B1 (de) Indol-Carboxamid-Derivate und ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten
CH661512A5 (fr) 1-pyridyloxy-3-indolylalkylamino-propanols substitues et leur preparation.
EP0687252A1 (de) 2-phenoxyethylaminderivate, ihre herstellung und ihre therapeutische anwendung
CH620678A5 (en) Process for the preparation of a derivative of piperidine
EP0099822B1 (de) 1-(2-Carbalkoxy-4-(thienylalkylamido)phenoxy)-3-amino-2-propanole, ihre Herstellung und ihre Verwendungen in Therapie
EP0094303B1 (de) Amide, ihre Salze, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
EP0103500A2 (de) Phenethyl-1-alpha-phenyl-piperidin-3-propannitril-Derivate, ihre Herstellung und therapeutische Verwendung
FR2523129A1 (fr) Derives de 3-azetidinylethyl-1-phenyl-2-imidazolidinone, medicaments les contenant et procede pour leur preparation